01 September 2017
: Case report
Recurrent Cardiovascular Events Despite Antiplatelet Therapy in a Patient with Polycythemia Vera and Accelerated Platelet Turnover
Unusual clinical course, Unusual or unexpected effect of treatment
Oliver Heidmann Pedersen12CDEF*, Mads Lamm Larsen13CDEF, Steen Dalby Kristensen14DEF, Anne-Mette Hvas24DEF, Erik Lerkevang Grove14ADEFDOI: 10.12659/AJCR.904148
Am J Case Rep 2017; 18:945-948
Abstract
BACKGROUND: Clopidogrel is commonly used in the prevention and treatment of cardiovascular events. However, despite clopidogrel treatment, some patients experience recurrent ischemic events.
CASE REPORT: We present the case of a 58-year-old man with polycythemia vera and concomitant thrombocytosis who suffered 6 episodes of cerebral infarctions and 1 myocardial infarction, despite treatment with clopidogrel. Following his last ischemic event, the antiplatelet therapy was intensified from initially clopidogrel monotherapy to dual antiplatelet therapy with aspirin 75 mg once daily and ticagrelor 90 mg twice daily. Since then, no cardiovascular event has been reported.
CONCLUSIONS: This case report illustrates that insufficient platelet inhibition with clopidogrel monotherapy in a patient with thrombocytosis may be associated with recurrent arterial thrombosis. The exact reasons for the insufficient platelet inhibition are not known, but a plausible explanation may be an accelerated platelet turnover reflected by an increased number of immature platelets in this patient.
Keywords: Blood Platelets, Platelet Aggregation, Platelet Aggregation Inhibitors, Platelet Count, Purinergic P2Y Receptor Antagonists, Thrombocytosis
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947938
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947163
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949194
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948731
Most Viewed Current Articles
21 Jun 2024 : Case report
101,839
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
54,458
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
38,088
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
25,936
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200